Pacific Biosciences
PACB
#3382
Rank
$2.66 B
Marketcap
$11.78
Share price
-1.75%
Change (1 day)
25.05%
Change (1 year)

Operating Margin for Pacific Biosciences (PACB)

Operating Margin as of January 2023 (TTM): -217.57%

According to Pacific Biosciences 's latest financial reports and stock price the company's current Operating Margin is -217.57%. At the end of 2021 the company had an Operating Margin of -201.01%.

Operating Margin history for Pacific Biosciences from 2010 to 2022

Operating Margin at the end of each year

Year Operating Margin Change
2021-201.01%-634.48%
202037.61%-141.93%
2019-89.69%-29.58%
2018-127.36%33.35%
2017-95.51%21.78%
2016-78.42%152.91%
2015-31.01%-70.33%
2014-104.52%-61.66%
2013-272.58%-24.93%
2012-363.08%12.02%
2011-324.12%-96.13%
2010-8,377.18%-87.16%
2009-65,237.04%1211.76%
2008-4,973.25%359.88%
2007-1,081.41%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
17.94%-100.02%๐Ÿ‡บ๐Ÿ‡ธ USA
-4.96%-100.01%๐Ÿ‡บ๐Ÿ‡ธ USA
19.53%-100.03%๐Ÿ‡บ๐Ÿ‡ธ USA
18.31%-100.02%๐Ÿ‡บ๐Ÿ‡ธ USA
N/A-100.00%๐Ÿ‡บ๐Ÿ‡ธ USA
-101.08%-100.02%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.